手術前合併化學與放射治療--低位直腸癌病患治療的新趨勢 病人於術前合併化學與放射治療療程後，接受了低位直腸切除手術與結腸肛門吻合 ... 對於腫瘤很大或位置很低的直腸癌的病人，以前多半在腫瘤切除、直腸吻合後， ...
Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in 1. Lancet Oncol. 2012 Feb;13(2):163-71. doi: 10.1016/S1470-2045(11)70320-5. Epub 2011 Dec 7. Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal ...
Definitive concurrent chemoradiotherapy in cervical cancer - a university of malaya medical centre e 1. Asian Pac J Cancer Prev. 2014;15(20):8987-92. Definitive concurrent chemoradiotherapy in cervical cancer - a university of malaya medical centre experience. Zamaniah WW, Mastura M, Phua C, Adlinda A, Marniza S, Rozita A. BACKGROUND: The efficacy of ...
Head & Neck Oncology | Full text | Concurrent chemoradiotherapy with carboplatin followed by carbopl This study aimed to evaluate acute major toxicities, the response rate, 3-year overall survival and progression-free survival rate of locally advanced nasopharyngeal carcinoma patients on concurrent carboplatin chemoradiotherapy followed by carboplatin an
BMC Cancer | Full text | Comparison of concurrent chemoradiotherapy versus neoadjuvant chemotherapy Combined radiotherapy and chemotherapy is considered the standard of care for locally advanced nasopharyngeal carcinoma (LA-NPC) in Epstein-Barr virus infection endemic area. This study compared the long-term outcomes between LA-NPC patients treated with
Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Abstract Purpose: To test the concept of taxane sequencing in combined-modality therapy, this phase II trial (S9504) evaluated consolidation docetaxel after concurrent chemoradiotherapy in patients with pathologically documented stage IIIB non–small ...
Radiation Oncology | Full text | Concurrent chemoradiotherapy in adjuvant treatment of breast cancer The optimal sequencing of chemotherapy and radiotherapy after breast surgery was largely studied but remains controversial. Concurrent chemo-radiotherapy is a valuable method for adjuvant treatment of breast cancer which is under ongoing research program
Concurrent Chemotherapy and Radiotherapy for Head and Neck Cancer therapy as in the intergroup 0099 trial.[16] The 3-year overall survival was improved with the addition of chemotherapy (80 vs 65%; p= 0.0061). As in the intergroup trial, grade 3-4 toxicity was more common in the chemoradiotherapy group. Distant failure
Induction Chemotherapy and Chemoradiotherapy in Nasopharyngeal Cancers - Full Text View - ClinicalTr This is a randomized, multicenter, phase III trial comparing induction chemotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) followed by concurrent chemoradiotherapy (Arm A) to concurrent chemoradiotherapy alone (Arm B), in nasopharyngeal cancer
Concurrent Chemotherapy and Radiotherapy for Head and Neck Cancer Table 1. Phase III Trials of Definitive Radiotherapy Versus Concurrent Chemoradiotherapy for Advanced Head and Neck Cancer. Trial Patients (n) Local control Toxicity (grade 3- 4) Distant metastases Overall survival Ref. Intergroup 0099 147 NPC Crude RT 74
